These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36712569)

  • 1. Hippocampal α5-GABA
    Perez SM; McCoy AM; Prevot TD; Mian MY; Carreno FR; Frazer A; Cook JM; Sibille E; Lodge DJ
    Biol Psychiatry Glob Open Sci; 2023 Jan; 3(1):78-86. PubMed ID: 36712569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive Allosteric Modulation of α5-GABAA Receptors Reverses Stress-Induced Alterations in Dopamine System Function and Prepulse Inhibition of Startle.
    McCoy AM; Prevot TD; Mian MY; Cook JM; Frazer A; Sibille EL; Carreno FR; Lodge DJ
    Int J Neuropsychopharmacol; 2022 Aug; 25(8):688-698. PubMed ID: 35732272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia.
    Gill KM; Lodge DJ; Cook JM; Aras S; Grace AA
    Neuropsychopharmacology; 2011 Aug; 36(9):1903-11. PubMed ID: 21562483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GL-II-73, a Positive Allosteric Modulator of α5GABA
    McCoy AM; Prevot TD; Sharmin D; Cook JM; Sibille EL; Lodge DJ
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of a tonic inhibitory conductance in mouse hippocampal neurones by negative allosteric modulators of α5 subunit-containing γ-aminobutyric acid type A receptors: implications for treating cognitive deficits.
    Manzo MA; Wang DS; Li WW; Pinguelo A; Popa MO; Khodaei S; Atack JR; Ross RA; Orser BA
    Br J Anaesth; 2021 Mar; 126(3):674-683. PubMed ID: 33388140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α5-GABAA Receptor Modulation Reverses Behavioral and Neurophysiological Correlates of Psychosis in Rats with Ventral Hippocampal Alzheimer's Disease-like Pathology.
    Eassa NE; Perez SM; Boley AM; Elam HB; Sharmin D; Cook JM; Lodge DJ
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.
    Gill KM; Cook JM; Poe MM; Grace AA
    Schizophr Bull; 2014 Mar; 40(2):341-50. PubMed ID: 24464874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABA
    Kiemes A; Gomes FV; Cash D; Uliana DL; Simmons C; Singh N; Vernon AC; Turkheimer F; Davies C; Stone JM; Grace AA; Modinos G
    Neuropsychopharmacology; 2022 Feb; 47(3):687-695. PubMed ID: 34743200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orexin Modulation of VTA Dopamine Neuron Activity: Relevance to Schizophrenia.
    Perez SM; Lodge DJ
    Int J Neuropsychopharmacol; 2021 Apr; 24(4):344-353. PubMed ID: 33587746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vagal nerve stimulation reverses aberrant dopamine system function in the methylazoxymethanol acetate rodent model of schizophrenia.
    Perez SM; Carreno FR; Frazer A; Lodge DJ
    J Neurosci; 2014 Jul; 34(28):9261-7. PubMed ID: 25009259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085.
    de Lucas AG; Ahring PK; Larsen JS; Rivera-Arconada I; Lopez-Garcia JA; Mirza NR; Munro G
    Biochem Pharmacol; 2015 Feb; 93(3):370-9. PubMed ID: 25542996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of extrasynaptic GABA
    Donegan JJ; Boley AM; Yamaguchi J; Toney GM; Lodge DJ
    Nat Commun; 2019 Jun; 10(1):2819. PubMed ID: 31249307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripubertal mGluR2/3 Agonist Treatment Prevents Hippocampal Dysfunction and Dopamine System Hyperactivity in Adulthood in MAM Model of Schizophrenia.
    Sonnenschein SF; Grace AA
    Schizophr Bull; 2021 Oct; 47(6):1806-1814. PubMed ID: 33928393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrasynaptic localization is essential for α5GABA
    McCoy AM; Prevot TD; Mian MY; Sharmin D; Ahmad AN; Cook JM; Sibille EL; Lodge DJ
    bioRxiv; 2023 Jul; ():. PubMed ID: 37502875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescent stress contributes to aberrant dopamine signaling in a heritable rodent model of susceptibility.
    Perez SM; Lodge DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109701. PubMed ID: 31299274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive and Negative Selective Allosteric Modulators of α5 GABAA Receptors: Effects on Emotionality, Motivation, and Motor Function in the 5xFAD Model of Alzheimer's Disease.
    Aranđelović J; Santrač A; Batinić B; Todorović L; Ahmed Khan MZ; Rashid F; Poe MM; Obradović A; Cook JM; Savić MM
    J Alzheimers Dis; 2021; 84(3):1291-1302. PubMed ID: 34657887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative Allosteric Modulation of Gamma-Aminobutyric Acid A Receptors at α5 Subunit-Containing Benzodiazepine Sites Reverses Stress-Induced Anhedonia and Weakened Synaptic Function in Mice.
    Troppoli TA; Zanos P; Georgiou P; Gould TD; Rudolph U; Thompson SM
    Biol Psychiatry; 2022 Aug; 92(3):216-226. PubMed ID: 35120711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prepubertal Environmental Enrichment Prevents Dopamine Dysregulation and Hippocampal Hyperactivity in MAM Schizophrenia Model Rats.
    Zhu X; Grace AA
    Biol Psychiatry; 2021 Feb; 89(3):298-307. PubMed ID: 33357630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Modulation of α5 GABA
    Petrache AL; Khan AA; Nicholson MW; Monaco A; Kuta-Siejkowska M; Haider S; Hilton S; Jovanovic JN; Ali AB
    Front Cell Neurosci; 2020; 14():568194. PubMed ID: 33262690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches to the management of schizophrenia: focus on aberrant hippocampal drive of dopamine pathways.
    Perez SM; Lodge DJ
    Drug Des Devel Ther; 2014; 8():887-96. PubMed ID: 25061280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.